Class information for:
Level 1: NEPHROGENIC SYSTEMIC FIBROSIS//NEPHROGENIC FIBROSING DERMOPATHY//GADOLINIUM

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
6848 1360 27.4 79%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1649 6378 CONTRAST INDUCED NEPHROPATHY//NEPHROGENIC SYSTEMIC FIBROSIS//CONTRAST MEDIA

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 NEPHROGENIC SYSTEMIC FIBROSIS Author keyword 331 80% 15% 205
2 NEPHROGENIC FIBROSING DERMOPATHY Author keyword 131 90% 4% 56
3 GADOLINIUM Author keyword 47 12% 26% 350
4 GADODIAMIDE Author keyword 45 64% 3% 44
5 GADOLINIUM BASED CONTRAST AGENTS Author keyword 34 70% 2% 28
6 NEPHROGENIC SYSTEMIC FIBROSIS NSF Author keyword 23 79% 1% 15
7 GADOVERSETAMIDE Author keyword 23 100% 1% 10
8 GADOTERIDOL Author keyword 22 66% 2% 21
9 GADOBUTROL Author keyword 15 40% 2% 30
10 GADOLINIUM CHELATES Author keyword 13 46% 2% 22

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 NEPHROGENIC SYSTEMIC FIBROSIS 331 80% 15% 205 Search NEPHROGENIC+SYSTEMIC+FIBROSIS Search NEPHROGENIC+SYSTEMIC+FIBROSIS
2 NEPHROGENIC FIBROSING DERMOPATHY 131 90% 4% 56 Search NEPHROGENIC+FIBROSING+DERMOPATHY Search NEPHROGENIC+FIBROSING+DERMOPATHY
3 GADOLINIUM 47 12% 26% 350 Search GADOLINIUM Search GADOLINIUM
4 GADODIAMIDE 45 64% 3% 44 Search GADODIAMIDE Search GADODIAMIDE
5 GADOLINIUM BASED CONTRAST AGENTS 34 70% 2% 28 Search GADOLINIUM+BASED+CONTRAST+AGENTS Search GADOLINIUM+BASED+CONTRAST+AGENTS
6 NEPHROGENIC SYSTEMIC FIBROSIS NSF 23 79% 1% 15 Search NEPHROGENIC+SYSTEMIC+FIBROSIS+NSF Search NEPHROGENIC+SYSTEMIC+FIBROSIS+NSF
7 GADOVERSETAMIDE 23 100% 1% 10 Search GADOVERSETAMIDE Search GADOVERSETAMIDE
8 GADOTERIDOL 22 66% 2% 21 Search GADOTERIDOL Search GADOTERIDOL
9 GADOBUTROL 15 40% 2% 30 Search GADOBUTROL Search GADOBUTROL
10 GADOLINIUM CHELATES 13 46% 2% 22 Search GADOLINIUM+CHELATES Search GADOLINIUM+CHELATES

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 DERMOPATHY 342 72% 20% 270
2 GADODIAMIDE 150 68% 10% 130
3 GADODIAMIDE INJECTION 141 75% 8% 102
4 GADOPENTETATE DIMEGLUMINE 101 34% 18% 244
5 GADOLINIUM EXPOSURE 73 88% 3% 35
6 GADOTERIDOL 56 68% 4% 50
7 ALTERNATIVE CONTRAST AGENT 49 94% 1% 17
8 NEPHROGENIC SYSTEMIC FIBROSIS 34 19% 12% 164
9 RENAL DIALYSIS PATIENTS 24 63% 2% 24
10 IODINATED CONTRAST 23 45% 3% 38

Journals

Reviews



Title Publ. year Cit. Active
references
% act. ref.
to same field
Current status of nephrogenic systemic fibrosis 2014 11 64 98%
Nephrogenic Systemic Fibrosis 2012 30 42 100%
Current Status of Gadolinium Toxicity in Patients with Kidney Disease 2009 70 33 97%
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis 2014 10 36 78%
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis 2009 58 26 88%
Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance 2012 23 80 75%
Nephrogenic fibrosing dermopathy: the first 6 years 2003 165 11 82%
MRI Safety Update 2008: Part I, MRI Contrast Agents and Nephrogenic Systemic Fibrosis 2008 86 79 77%
Risk Factors for NSF: A Literature Review 2009 45 93 85%
MRI contrast agents: Basic chemistry and safety 2012 25 57 61%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 GLOBAL MED REGULATORY AFFAIRS 12 86% 0.4% 6
2 GLOBAL CLIN DEV DIAGNOST IMAGING 4 75% 0.2% 3
3 SCOTT WHITE CLIN HOSP 4 32% 0.7% 10
4 TRG DIAGNOST IMAGING 2 36% 0.4% 5
5 MED NEPHROL 3 2 67% 0.1% 2
6 DIAGNOST RADIOL 54E2 2 23% 0.5% 7
7 IMAGING SOLUT 1 50% 0.1% 2
8 RONTGEN STRAHLENKLIN 1 50% 0.1% 2
9 UO RISONANZA MAGNET 1 50% 0.1% 2
10 ZENT BILDGEBENDE DIAGNOST 1 29% 0.3% 4

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000213055 CO2 ANGIOGRAPHY//CARBON DIOXIDE ANGIOGRAPHY//CARBON DIOXIDE INJECTOR
2 0.0000137376 MR ANGIOGRAPHY//MAGNETIC RESONANCE MR VASCULAR STUDIES//MAGNETIC RESONANCE ANGIOGRAPHY
3 0.0000101941 RELAXIVITY//MRI CONTRAST AGENTS//GADOLINIUM COMPLEXES
4 0.0000096954 FLAIR//FLAIR SEQUENCE//CSF SUPPRESSION
5 0.0000076974 GD EOB DTPA//GADOXETIC ACID//GADOXETATE DISODIUM
6 0.0000076204 CONTRAST INDUCED NEPHROPATHY//CONTRAST INDUCED ACUTE KIDNEY INJURY//CONTRAST MEDIA
7 0.0000073612 ISOLATED MYELOPATHY//ENTANGLED HISTORIES//HLTH SCI MED RADIOL SCI
8 0.0000069059 MR RENOGRAPHY//FUNCTIONAL RENAL IMAGING//CORTICOMEDULLARY DIFFERENTIATION
9 0.0000067031 MOL MED MED BIOL ENGN//WATER PROTON RELAXIVITY//MOL SUR E PHYS NANOSCI
10 0.0000059442 RADIOGRAPHIC CONTRAST MEDIA//IOXAGLATE//CONTRAST MEDIA